Spleen removal surgery for cirrhosis patients with enlarged spleen
Part of Blood & lymphatic, Digestive system clinical trials.
This study looks at whether removing an enlarged spleen (splenectomy) in people with cirrhosis can improve their blood fat (lipid) levels over two years. It may help those with low blood counts due to an overactive spleen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have cirrhosis and an enlarged spleen that causes low blood counts
- Your liver function is at a moderate level (Child-Pugh A or B)
- You have not had bleeding from veins in your esophagus or stomach
- You have not had major abdominal surgery before
- You can attend follow-up visits for 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether removing an enlarged spleen through keyhole surgery can improve kidney function in people with cirrhosis and an overactive spleen. The trial follows patients for two years to see if the surgery helps protect the kidneys.
This study looks at whether removing the spleen using keyhole surgery can improve “liver reserve function” in people with cirrhosis. It may be considered for patients who have an enlarged spleen and very low platelets, but it also has several safety exclusions.
This study tests whether removing part of the liver along with the spleen during laparoscopic (keyhole) surgery helps improve liver function and the immune system in people with liver cancer and cirrhosis. If you qualify, you may have better surgical outcomes and recovery.
This study tests a surgery (LSD) in people with liver cirrhosis who have had bleeding from enlarged veins in the food pipe or stomach. It looks at whether the surgery helps improve blood fat levels over two years, which might lower future risks.
This study is testing a keyhole surgery to remove part of an enlarged spleen in people with cirrhosis. It aims to improve low blood counts and reduce the risk of further bleeding from stomach or esophagus veins.
This trial looks at whether a minimally invasive spleen surgery (with a specific vein-disconnection procedure) can better protect liver function in people with cirrhosis who have had variceal bleeding. It may help reduce stress on the liver after treatment, but you must meet several safety criteria.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.